Skip Navigation

European Heart Journal 1985 6(1):85-90;
Copyright © 1985 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by GARCIA-DORADO, D.
Right arrow Articles by GARCIA-DORADO, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GARCIA-DORADO, D.
Right arrow Articles by GARCIA-DORADO, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1985 The European Society of Cardiology

Mitral valve prolapse secondary to right ventricular enlargement in patients with pulmonary hypertension after toxic rapeseed oil ingestion

D. GARCIA-DORADO, E. J. GARCIA, L. BELLO, E. MAROTO, A. ALMAZÁN, A. GOMEZ, F. FERNANDEZ-AVILES and A. GARCIA-DORADO

Departments of Cardiology and Pediatrics, Hospital Provincial de Madrid Doctor Esquerdo 46, Madrid-30, España

Received 10 July 1984; revised 12 October 1984; .

Request for reprints to: Dr David Garcia-Dorado, Servicio de Cardiologia. Hospital Provincial de Madrid, Doctor Esquerdo 46,Madrid-30, España.

Abstract

A high incidence of mitral valve prolapse (MVP) has been reported in various entities which produce important right ventricular (RV) enlargement with normal or decreased left ventricular (LV) volume. To evaluate the importance of RV enlargement in the genesis of MVP in these cases, we analyzed the echocardiographic studies from 176 patients with ‘Síndrome Tóxico’. These patients underwent M-mode, cross-sectional and pulsed Doppler examination because of the suspicion of having dietary pulmonary hypertension, a complication which occurred in almost 20% of patients with this epidemic poisoning and which showed a course of gradual resolution in most of them. RV size was classified according to the RV/LV maximal short-axis dimension ratio as normal, border-line, moderately enlarged and severely enlarged. MPV was diagnosed according to standard M-mode and cross-sectional echocardiographic criteria. A second echocardiographic examination was obtained in 38 patients 12.5±5.3 months after the first one.

The incidence of MVP was 9.3% in patients with normal RV size (N=107), 9.5% in patients with border-line RV size (N=23), 30% in patients with moderate RV enlargement (N=30) and 56% in patients with severe RV enlargement (N=16) (P>0.001). Fourteen (77%) of the 18 patients with MVP and moderate or severe RV enlargement had holosystolic MVP. At pulsed Doppler examination, no patient showed signs of mitral regurgitation. Of the 38 patients with serial studies, 6 had moderate or severe RV enlargement and MVP; in the last study 3 of them had normal RV size and did not show MVP but the other 3, with persistent moderate or severe RV enlargement were shown to have MVP (P<0.005). These data confirm that important RV enlargement may produce secondary MVP in some patients without left-sided cardiac abnormalities.

Key Words: Mitral valve prolapse • right ventricular enlargement • dietary pulmonary hypertension


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sundaram, M. Carnethon, K. Polito, A. H. Kadish, and J. J. Goldberger
Autonomic effects on QT-RR interval dynamics after exercise
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H490 - H497.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. L. Strevel, D. J. Ing, and L. L. Siu
Molecularly Targeted Oncology Therapeutics and Prolongation of the QT Interval
J. Clin. Oncol., August 1, 2007; 25(22): 3362 - 3371.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Schulze-Bahr
Arrhythmia Predisposition: Between Rare Disease Paradigms and Common Ion Channel Gene Variants
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A67 - A78.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. M. Shoup, D. R. Elmaleh, A. A. Bonab, and A. J. Fischman
Evaluation of trans-9-18F-Fluoro-3,4-Methyleneheptadecanoic Acid as a PET Tracer for Myocardial Fatty Acid Imaging
J. Nucl. Med., February 1, 2005; 46(2): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R. Bezzina, A. O. Verkerk, A. Busjahn, A. Jeron, J. Erdmann, T. T. Koopmann, Z. A. Bhuiyan, R. Wilders, M. M.A.M. Mannens, H. L. Tan, et al.
A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization
Cardiovasc Res, July 1, 2003; 59(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. M. Al-Khatib, N. M. A. LaPointe, J. M. Kramer, and R. M. Califf
What Clinicians Should Know About the QT Interval
JAMA, April 23, 2003; 289(16): 2120 - 2127.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Halkin, A. Roth, I. Lurie, R. Fish, B. Belhassen, and S. Viskin
Pause-dependent torsade de pointes following acute myocardial infarction: A variant of the acquired long QT syndrome
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. D. Oakes, A. Kjellstedt, G.-B. Forsberg, T. Clementz, G. Camejo, S. M. Furler, E. W. Kraegen, M. Ölwegård-Halvarsson, A. B. Jenkins, and B. Ljung
Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer
J. Lipid Res., June 1, 1999; 40(6): 1155 - 1169.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
T. O. Cheng and J. B. Barlow
Mitral Leaflet Billowing and Prolapse: Its Prevalence Around the World
Angiology, February 1, 1989; 40(2): 77 - 87.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.